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Background: Human papillomavirus is associated with urogenital carcinogenesis such as penile and uterine cervix
cancer. On the other hand, association between human papillomavirus infection and risk of bladder and prostatic
cancer remains controversial.
Case presentation: We report a rare case of a 67-year-old Japanese man with synchronous triple urogenital cancer
including bladder small cell carcinoma, prostatic ductal adenocarcinoma, and penile squamous cell carcinoma,
who presented with a history of asymptomatic gross hematuria. Bladder small cell carcinoma and prostatic ductal
adenocarcinoma were diagnosed by histopathological examination after transurethral resection of the tumor.
Moreover, he was diagnosed with penile carcinoma based on the exfoliative cytodiagnosis of nodular and papillary
tumors inside the preputial collar. He was treated with laparoscopic radical cystectomy, urethrectomy, partial
penectomy with pelvic lymph node dissection, and ileal conduit urinary diversion.
To identify a common pathogenesis, we considered human papillomavirus as an etiologic factor because it is a
known risk factor for penile carcinoma. Human papillomavirus deoxyribonucleic acid bands were detected by
polymerase chain reaction in the three tumors. There was a possibility that human papillomavirus was involved
in the carcinogenesis of the triple cancer.
Conclusions: To the best of our knowledge, this is the first report of the synchronous triple urogenital cancer
of small cell carcinoma of the bladder, ductal adenocarcinoma of the prostate and penile squamous cell carcinoma.
We believe that human papillomavirus may have been involved in the carcinogenesis of the triple urogenital cancer
described in this case.
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Figure 1 T2-weighted magnetic resonance imaging showed a
locally-invasive tumor (arrows) on the right wall of the bladder
and a prostatic urethral tumor that protruded into the bladder
(arrowheads), without pelvic lymph node abnormalities.
Figure 2 Macroscopic image of resected en bloc urinary bladder,
prostate, urethra, and distal penis. Arrows indicate bladder tumor
and arrowheads indicate penile tumor.
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Small cell carcinoma of the bladder (SmCCB), ductal
adenocarcinoma of the prostate (DAP), and penile squa-
mous cell carcinoma (SCC) are relatively rare, each with a
morbidity rate of < 1.0 per 100,000 persons per year [1-4].
The etiology of penile cancer is reportedly multifactorial,
and human papillomavirus (HPV) is a known risk factor
for penile cancer development [4]. However, the causes of
SmCCB and DAP have not been elucidated. We report a
case of synchronous triple urogenital cancer, including
SmCCB, DAP, and penile SCC. Moreover, we discuss the
underlying common pathogenesis of the triple cancer.
Case presentation
A 67-year-old Japanese man presented to the hospital
with asymptomatic gross hematuria. He had been smok-
ing for 20 years (20 cigarettes/day). Cystoscopy before
transurethral resection (TUR) indicated a nonpapillary
sessile tumor on the right bladder wall and a papillary
pedunculated tumor on the bladder neck. Histopatho-
logical examination of TUR specimens showed muscle-
invasive SmCCB and DAP, after which he was referred
to our hospital.
Initial physical examination indicated phimosis and
nodular and papillary tumors inside the preputial collar.
Exfoliative cytodiagnosis of the penile tumor yielded posi-
tive results, and suggested SCC. Urinalysis showed hema-
topyuria, and the urinary cytology results were positive.
Serum tumor markers including neuron-specific enolase,
pro-gastrin-releasing peptide, and prostate-specific and
SCC antigens were within normal limits. Magnetic reson-
ance imaging revealed a locally, muscle-invasive bladder
tumor. Moreover, a prostatic urethral tumor protruding
into the bladder (Figure 1) and a non-invasive penile
tumor were identified, without pelvic lymph node swell-
ing. No remarkable lesions including bone and lung were
identified on computed tomography or bone scintigraphy.
He was diagnosed with synchronous triple cancer of the
bladder, prostate, and penis. He underwent laparoscopic
radical cystectomy, urethrectomy, and partial penectomy
with an ileal conduit urinary diversion. The obturator and
external ilieal lymph nodes were also dissected. No opera-
tive complications were noted.
The bladder tumor appeared well-circumscribed and
solid on gross examination. No tumors were observed in
the prostatic urethra. The nodular and papillary penile
tumors were located inside the preputial collar (Figure 2).
Hematoxylin and eosin (HE) staining of bladder tissue
revealed small and round tumor cells closely arranged in
cords (Figure 3a). They exhibited positive staining for the
neuroendocrine markers synaptophysin (data not shown)
and cluster of differentiation (CD 56) (Figure 3b). There-
fore, the bladder tumor was diagnosed as a SmCCB
(pT3aN0M0). Microscopically, no malignant tumor cellswere observed in the prostate. However, HE staining of
the TUR specimen was positive for DAP (Figure 3c),
which means DAP was completely resected by TUR. HE
staining of the penis specimen demonstrated papillary
tumor invasion of the submucosal stroma. Furthermore,
cancer pearls and single-cell keratinocytes—characteristic
of SCC—were found in the penile tumor (Figure 3d), and
therefore, it was diagnosed as SCC (pT1N0M0). Thus, he
was diagnosed with synchronous triple urogenital cancer,
including SmCCB, DAP, and penile SCC.
Figure 3 Histological findings showed triple cancer (magnification of background image: ×40, insert: ×400). (a) Hematoxylin-eosin (HE)
staining of the small cell carcinoma of the bladder. (b) Immunohistochemical staining for CD56 demonstrated CD56-positive cells. (c) HE staining
of the prostatic urethral tumor demonstrated papillary growth and malignancy. (d) HE staining of the penis showed cancer pearls and single-cell
keratinocytes that are characteristic of squamous cell carcinoma.
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polymerase chain reaction (PCR) tests by using a HPV
typing set (6603, Takara Bio Inc). This assay can detect
low-risk HPV types, including HPV-6, 11 and high-risk
types including HPV-16, 18, 31, 33, 35, 52b. HPV- de-
oxyribonucleic acid (DNA) containing the domains asso-
ciated with carcinogenesis (E6 and E7). The assay can
amplify PCR products for these domains were detected
in all three cancers (Figure 4). Moreover, to examine cell
apoptosis, immunohistochemical staining was conducted.
Sections were incubated with monoclonal mouse anti-
human antibodies for p53 (1:200, Dako) and bcl-2 (1:100,
Dako) at 4°C overnight. Next, sections for p53 and bcl-2
were treated with anti-mouse immunoglobulins (VectorFigure 4 Human papillomavirus deoxyribonucleic acid was
detected by polymerase chain reaction (arrow) in the
tumor tissue.Laboratories) for 30 min at room temperature. We ob-
tained positive staining for p53 and bcl-2 in all three
cancers (Figure 5).
Since SmCCB was pathologically invasive, the patient
underwent adjuvant chemotherapy with cisplatin and iri-
notecan, based on the treatment regimen for small cell
lung cancer. The patient is currently alive at 6 months
postoperatively without evidence of tumor recurrence.
Discussion
SmCCB, DAP, and penile SCC are relatively rare. To iden-
tify a common pathogenesis, we considered HPV as an
etiologic factor because it is a known risk factor for penile
carcinoma. According to their meta-analysis, Li et al. dem-
onstrated a link between bladder cancer and HPV infec-
tion based on a significantly increased odds ratio for HPV
positivity [5]. Furthermore, recent studies have shown a
positive correlation between HPV and prostatic adenocar-
cinoma risk [6,7]. It is known that the oncogenic effect of
HPV is induced through expression of the oncoproteins
E6 and E7 [8]. Therefore, we used the HPV assay kit to
identify the variants of HPV associated with the high risk
of carcinogenesis. HPV PCR yielded positive results in
these tumor cells. HPV serotypes are classified according
to low or high oncogenicity into low- or high-risk groups.
The latter are known to have a strong oncogenic effect.
Thus, our findings suggest that HPV may be the cause of
SmCCB, DAP, and penile SCC in this case. However, no
positive correlation has been reported between HPV and
prostatic adenocarcinoma [9]. Furthermore, Polesel stated
that HPV was not involved in the development of bladder
Figure 5 Immunohistochemical staining showed positive staining for p53 and bcl-2 (arrows) in all three cancers (magnification of
background image: ×40).
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findings because our pathological findings differed from
those in previous cases. Further studies such as immuno-
logical and genetic basic experiments may clarify whether
HPV contributes to the carcinogenesis of DAP and
SmCCB.
The E6 oncoprotein complex, synthesized during HPV
infection, facilitates the degradation of p53 protein [4,10]
leading to an increased variation of the p53 protein. Con-
sequently, there is an increased expression of bcl-2, which
is involved in tumor suppression. Immunohistochemical
study demonstrated that variant p53 and bcl-2 proteins
were increased in the patient’s bladder, prostate, and penis
tumor cells. Thus, we consider the following carcino-
genesis mechanism in this case: the degradation of p53
by HPV infection induced cell-cycle dysfunction and
caused bcl-2 gene activation, apoptosis suppression,
and carcinogenesis.
This study suggests a probability that HPV was linked
with carcinogenesis resulting in bladder, prostate, and
penile cancers. In addition, it is believed that HPV infected
through the urinary tract by the intercourse. However,
more detailed information on the association between
HPV infection and urogenital cancer is required.Conclusions
We described a rare case of synchronous triple urogenital
cancer including SmCCB, DAP, and penile SCC. To the
best of our knowledge, this is the first report of the
synchronous triple urogenital cancer of SmCCB, DAP and
penile SCC. We believe that HPV may have been involved
in the carcinogenesis of the triple urogenital cancer
described in this case.Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
images. A copy of the written consent is available for
review by the Editor of this journal.
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